Dr. Rugo: Identification and Treatment of Patients with HR+, HER2- EBC at a High Risk of Recurrence
Watch Dr. Rugo as she shares vital insights on identifying and managing patients with HR+, HER2- early breast cancer at high risk of recurrence. Learn about unmet needs, high-risk features, and treatment options to help individualize patient care.
Date of Last Review: October 10, 2024
Document Number: VV-MED-160291
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice